Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000146

Chairperson & CEO sold 9,500 shares at an average $494.55 ($4,698,271)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-21 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-21 Sale : show line 2 in the form 10b5-1 −1,520 $492.97 $749,321 332,423 I
2026-09-21 Sale : show line 3 in the form 10b5-1 −2,680 $493.60 $1,322,851 329,743 I
2026-09-21 Sale : show line 4 in the form 10b5-1 −2,170 $494.82 $1,073,751 327,573 I
2026-09-21 Sale : show line 5 in the form 10b5-1 −2,287 $495.71 $1,133,694 325,286 I
2026-09-21 Sale : show line 6 in the form 10b5-1 −843 $496.62 $418,654 324,443 I
Open-market sales · 9,500 sh · avg $494.55 · $4,698,271

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-21 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option −9,500 394,910 I
Loading xslF345X06/primarydocument.xml…